For example, loading of TLR-activating microRNAs (i.e., miR-142) [127] or IL-12 on tumor-derived EVs and silencing of TGF-β1 induced greater anti-tumor responses compared to unmanipulated EVs [128,129]. This evidence concerns the gene TGFB1 and neoplasm.